Reply: A bias in genotyping of the ERBB2 (HER2) Ile655Val variant

Carcinogenesis

Volumn 26, Issue 12, 2005, Pages 2213-

  Benusiglio, Patrick R ^a   Luccarini, Craig ^a   Ajai, Oluseun ^a   Ponder, Bruce A J ^a   Pharoah, Paul D ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ACCURACY; GENE SEQUENCE; GENE TARGETING; GENETIC VARIABILITY; GENOTYPE; LETTER; PLOTS AND CURVES; PRIORITY JOURNAL; PROCESS DESIGN; PROTEIN BINDING; RELIABILITY; SINGLE NUCLEOTIDE POLYMORPHISM;

BREAST NEOPLASMS; GENOTYPE; HUMANS; ISOLEUCINE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, ERBB-2; VALINE; VARIATION (GENETICS);

EID: 27944497428     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgi181     Document Type: Letter

References (2)

1. Frank,B., Hemminki,K., and Burwinkel,B. (2005) A bias in genotyping the ERBB2 (Her2) Ile655Val variant. Carcinogenesis, 26, 1649.
2. Benusiglio,P.R., Lesueur,F., Luccarini,C., Conroy,D.M., Shah,M., Easton,D.F., Day,N.E., Dunning,A.M., Pharoah,P.D. and Ponder,B.A. (2005) Common ERBB2 polymorphisms and risk of breast cancer in a white British population: A case-control study. Breast Cancer Res., 7, R204-R209.